Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital’s Yaffee
Len Yaffee, Kessef Capital, join 'Fast Money' to talk Amgen's obesity drug, Eli Lilly's current stock action, and much more. ...
Len Yaffee, Kessef Capital, join 'Fast Money' to talk Amgen's obesity drug, Eli Lilly's current stock action, and much more. ...
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.